Chemical structure of dimethyltryptamine
Find information on thousands of medical conditions and prescription drugs.

Dimethyltryptamine

Dimethyltryptamine, also known as DMT and N,N-dimethyltryptamine, not to be confused with 5-MeO-DMT, is a hallucinogenic tryptamine, similar in structure to the neurotransmitter serotonin. DMT is created in small amounts by the human body during normal metabolism. Pure DMT at room temperature is a colorless waxy or crystalline solid. DMT was first chemically synthesized in 1931. It also occurs naturally in many species of plants. DMT-containing plants are used in several South American shamanic practices. more...

Home
Diseases
Medicines
A
B
C
D
Dacarbazine
Dactinomycin
Dalmane
Danazol
Dantrolene
Dapoxetine
Dapsone
Daptomycin
Daraprim
Darvocet
Darvon
Daunorubicin
Daunorubicin
Daypro
DDAVP
Deca-Durabolin
Deferoxamine
Delsym
Demeclocycline
Demeclocycline
Demerol
Demulen
Denatonium
Depakene
Depakote
Depo-Provera
Desferal
Desflurane
Desipramine
Desmopressin
Desogen
Desogestrel
Desonide
Desoxyn
Desyrel
Detrol
Dexacort
Dexamethasone
Dexamfetamine
Dexedrine
Dexpanthenol
Dextran
Dextromethorphan
Dextromoramide
Dextropropoxyphene
Dextrorphan
Diabeta
Diacerein
Diacetolol
Dial
Diamox
Diazepam
Diazoxide
Dibenzepin
Diclofenac
Diclohexal
Didanosine
Dieldrin
Diethylcarbamazine
Diethylstilbestrol
Diethyltoluamide
Differin
Diflucan
Diflunisal
Digitoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dihydrotachysterol
Dilantin
Dilaudid
Diltahexal
Diltiazem
Dimenhydrinate
Dimercaprol
Dimetapp
Dimethyl sulfoxide
Dimethyltryptamine
Dimetridazole
Diminazene
Diovan
Dioxybenzone
Diphenhydramine
Diphenoxylate
Dipipanone
Dipivefrine
Diprivan
Diprolene
Diproteverine
Dipyridamole
Disulfiram
Disulfiram
Dizocilpine
Dobutamine
Docetaxel
Docusate sodium
Dofetilide
Dolasetron
Dolobid
Dolophine
Domperidone
Donepezil
Dopamine
Dopram
Doral
Doramectin
Doriden
Dornase alfa
Doryx
Dostinex
Doxapram
Doxazosin
Doxepin
Doxil
Doxil
Doxorubicin
Doxy
Doxycycline
Doxyhexal
Doxylamine
Drisdol
Drixoral
Dronabinol
Droperidol
Drospirenone
Duloxetine
Durabolin
Duragesic
Duraphyl
Duraquin
Dutasteride
Dv
Dyclonine
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

It is one of the main active constituents of snuffs like yopo and of the drink ayahuasca.

DMT is not orally active unless it is combined with a monoamine oxidase inhibitor (MAOI), such as harmaline. Without an MAOI, the body quickly metabolizes DMT, and it therefore has no significant hallucinogenic effect.

Hallucinogenic properties

DMT is a powerful psychoactive substance. If DMT is smoked, injected, or orally ingested with an MAOI, it can produce powerful entheogenic experiences including true hallucinations (perceived extensions of reality). A trip sitter is often employed to assist the drug user in staying physically and mentally healthy, and, in the case of smoked DMT, to catch the pipe when the user loses awareness of it.

Smoked: If DMT is smoked, the maximal effects last for a short period of time (30 minutes +). The onset after inhalation is very fast (less than 45 seconds) and maximal effects are reached within about a minute.

Insufflation: If DMT is insufflated (snorted through the nostrils) it will last slightly longer than if smoked and has less powerful effects.

Injection: Injected DMT produces an experience similar to inhalation in duration, intensity, and characteristics, although by some accounts it is more emotionally clinical (versus spiritual).

Oral ingestion: DMT, which is broken down by the digestive enzyme monoamine oxidase, is inactive if taken orally, unless combined with a monoamine oxidase inhibitor (MAOI). The shamanic potion ayahuasca, or yage, is a tea-like admixture of the boiled leaves, bark or roots of a variety of plants, usually including Psychotria viridis, which contains high levels of DMT, and Banisteriopsis caapi, which contains harmala alkaloids that are powerful MAOIs. A common source in the western US is Reed canary grass or Phalaris arundinacea, and Harding grass or Phalaris aquatica. This invasive grass contains high levels of DMT and other alkaloids . Taken orally with an appropriate MAOI, DMT produces a long lasting (over 1 hour), slow onset, high intensity experience. MAOIs should be used with extreme caution as they can make common over-the-counter drugs and foods toxic.

Induced DMT experiences can include profound time-dilation, visual and audio hallucinations, percieved journeys to paranormal realms, and encounters with spiritual beings or other experiences that, by most first hand accounts, defy verbal or visual description.

In a 1988 study conducted at UNM, psychiatrist Rick Strassman found that approximately 20% of volunteers injected with high doses of DMT had experiences identical to purported alien abductions.

Read more at Wikipedia.org


[List your site here Free!]


Hallucinations
From Gale Encyclopedia of Medicine, 4/6/01 by Paula Anne Ford-Martin

Definition

Hallucinations are false or distorted sensory experiences that appear to be real perceptions. These sensory impressions are generated by the mind rather than by any external stimuli, and may be seen, heard, felt, and even smelled or tasted.

Description

A hallucination occurs when environmental, emotional, or physical factors such as stress, medication, extreme fatigue, or mental illness cause the mechanism within the brain that helps to distinguish conscious perceptions from internal, memory-based perceptions to misfire. As a result, hallucinations occur during periods of consciousness. They can appear in the form of visions, voices or sounds, tactile feelings (known as haptic hallucinations), smells, or tastes.

Patients suffering from dementia and psychotic disorders such as schizophrenia frequently experience hallucinations. Hallucinations can also occur in patients who are not mentally ill as a result of stress overload or exhaustion, or may be intentionally induced through the use of drugs, meditation, or sensory deprivation. A 1996 report, published in the British Journal of Psychiatry, noted that 37% of 4,972 people surveyed experienced hypnagogic hallucinations (hallucinations that occur as a person is falling to sleep). Hypnopomic hallucinations (hallucinations that occur just upon waking) were reported by 12% of the sample.

Causes & symptoms

Common causes of hallucinations include:

  • Drugs. Hallucinogenics such as ecstasy (3,4-methylenedioxymethamphetamine, or MDMA), LSD (lysergic acid diethylamide, or acid), mescaline (3,4,5-trimethoxyphenethylamine, or peyote), and psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine, or mushrooms) trigger hallucinations. Other drugs such as marijuana and PCP have hallucinatory effects. Certain prescription medications may also cause hallucinations. In addition, drug withdrawal may induce tactile and visual hallucinations; as in an alcoholic suffering from delirium tremens (DTs).
  • Stress. Prolonged or extreme stress can impede thought processes and trigger hallucinations.
  • Sleep deprivation and/or exhaustion. Physical and emotional exhaustion can induce hallucinations by blurring the line between sleep and wakefulness.
  • Meditation and/or sensory deprivation. When the brain lacks external stimulation to form perceptions, it may compensate by referencing the memory and form hallucinatory perceptions. This condition is commonly found in blind and deaf individuals.
  • Electrical or neurochemical activity in the brain. A hallucinatory sensation--usually involving touch--called an aura, often appears before, and gives warning of, a migraine. Also, auras involving smell and touch (tactile) are known to warn of the onset of an epileptic attack.
  • Mental illness. Up to 75% of schizophrenic patients admitted for treatment report hallucinations.
  • Brain damage or disease. Lesions or injuries to the brain may alter brain function and produce hallucinations.

Diagnosis

Aside from hypnogogic and hypnopompic hallucinations, more than one event suggests a person should seek evaluation. A general physician, psychologist, or psychiatrist will try to rule out possible organic, environmental, or psychological causes through a detailed medical examination and social history. If a psychological cause such as schizophrenia is suspected, a psychologist will typically conduct an interview with the patient and his family and administer one of several clinical inventories, or tests, to evaluate the mental status of the patient.

Occasionally, people who are in good mental health will experience a hallucination. If hallucinations are infrequent and transitory, and can be accounted for by short-term environmental factors such as sleep deprivation or meditation, no treatment may be necessary. However, if hallucinations are hampering an individual's ability to function, a general physician, psychologist, or psychiatrist should be consulted to pinpoint their source and recommend a treatment plan.

Treatment

Hallucinations that are symptomatic of a mental illness such as schizophrenia should be treated by a psychologist or psychiatrist. Antipsychotic medication such as thioridazine (Mellaril), haloperidol (Haldol), chlorpromazine (Thorazine), clozapine (Clozaril), or risperidone (Risperdal) may be prescribed.

Prognosis

In many cases, chronic hallucinations caused by schizophrenia or some other mental illness can be controlled by medication. If hallucinations persist, psychosocial therapy can be helpful in teaching the patient the coping skills to deal with them. Hallucinations due to sleep deprivation or extreme stress generally stop after the cause is removed.

Key Terms

Aura
A subjective sensation or motor phenomenon that precedes and indicates the onset of a neurological episode, such as a migraine or an epileptic seizure.
Hypnogogic hallucination
A hallucination, such as the sensation of falling, that occurs at the onset of sleep.
Hypnopompic hallucination
A hallucination that occurs as a person is waking from sleep.
Sensory deprivation
A situation where an individual finds himself in an environment without sensory cues. Also, (used here) the act of shutting one's senses off to outside sensory stimuli to achieve hallucinatory experiences and/or to observe the psychological results.

Further Reading

For Your Information

    Books

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSMV-IV) Washington, DC: American Psychiatric Press, Inc., 1994.
  • Siegel, Ronald K. Fire in the Brain: Clinical Tales of Hallucination. New York: Dutton, 1992.

    Periodicals

  • Bental, R.P. "The Illusion of Reality: A Review and Integration of Psychological Research on Hallucinations." Psychological Bulletin 107, no. 1 (Jan 1990): 82-95.
  • Beyerstein, Barry L. "Believing is Seeing: Organic and Psychological Reasons for Hallucinations and Other Anomalous Psychiatric Symptoms." Medscape Mental Health 1, no. 11 (1996). http://www.medscape.com.
  • Ohayon, M.M., et al. "Hypnagogic and Hypnopompic Hallucinations: Pathological Phenomena?" The British Journal of Psychiatry 169 no. 4 (October 1996): 459-67.

    Organizations

  • American Psychological Association (APA). Office of Public Affairs. 750 First St. NE, Washington, DC 20002-4242. (202) 336-5700. http://www.apa.org/.
  • National Alliance for the Mentally Ill (NAMI). 200 North Glebe Road, Suite 1015, Arlington, VA 22203-3754. (800) 950-6264. http://www.nami.org.

Gale Encyclopedia of Medicine. Gale Research, 1999.

Return to Dimethyltryptamine
Home Contact Resources Exchange Links ebay